{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:24:33Z","timestamp":1791275073293,"version":"4.1.0"},"reference-count":196,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Governments of Bangladesh and Canada"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Tuberculosis (TB) is one of the leading causes of death due to infectious disease. It is a treatable disease; however, conventional treatment requires a lengthy treatment regimen with severe side effects, resulting in poor compliance among TB patients. Intermittent drug use, the non-compliance of patients, and prescription errors, among other factors, have led to the emergence of multidrug-resistant TB, while the mismanagement of multidrug-resistant TB (MDR-TB) has eventually led to the development of extensively drug-resistant tuberculosis (XDR-TB). Thus, there is an urgent need for new drug development, but due to the enormous expenses and time required (up to 20 years) for new drug research and development, new therapeutic approaches to TB are required. Host-directed therapies (HDT) could be a most attractive strategy, as they target the host defense processes instead of the microbe and thereby may prevent the alarming rise of MDR- and XDR-TB. This paper reviews the progress in HDT for the treatment of TB using repurposed drugs which have been investigated in clinical trials (completed or ongoing) and plant-derived natural products that are in clinical or preclinical trial stages. Additionally, this review describes the existing challenges to the development and future research directions in the implementation of HDT.<\/jats:p>","DOI":"10.3390\/biom14121497","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T05:21:32Z","timestamp":1732512092000},"page":"1497","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8116-4511","authenticated-orcid":false,"given":"Rubhana","family":"Raqib","sequence":"first","affiliation":[{"name":"Immunobiology, Nutrition and Toxicology Unit, Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-7813","authenticated-orcid":false,"given":"Protim","family":"Sarker","sequence":"additional","affiliation":[{"name":"Immunobiology, Nutrition and Toxicology Unit, Nutrition Research Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka 1212, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"key":"ref_1","unstructured":"(2024). WHO Guidelines Approved by the Guidelines Review Committee. WHO Consolidated Guidelines on Tuberculosis: Module 6: Tuberculosis and Comorbidities, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jam.14478","article-title":"Recent updates on drug resistance in Mycobacterium tuberculosis","volume":"128","author":"Singh","year":"2020","journal-title":"J. Appl. Microbiol."},{"key":"ref_3","first-page":"e49374","article-title":"Diabetes Mellitus and Prevalence of Other Comorbid Conditions: A Systematic Review","volume":"15","author":"Bodke","year":"2023","journal-title":"Cureus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MCP.0000000000001070","article-title":"Multidrug-resistant tuberculosis: Latest opinions on epidemiology, rapid diagnosis and management","volume":"30","author":"Nyasulu","year":"2024","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijid.2023.04.392","article-title":"Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis","volume":"132","author":"Diriba","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_6","unstructured":"WHO (2023). Global Tuberculosis Report, WHO."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ahmed, S., Raqib, R., Guethmundsson, G.H., Bergman, P., Agerberth, B., and Rekha, R.S. (2020). Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010021"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bergman, P., Raqib, R., Rekha, R.S., Agerberth, B., and Gudmundsson, G.H. (2020). Host Directed Therapy Against Infection by Boosting Innate Immunity. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01209"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/femsre\/fuz006","article-title":"Mycobacterium tuberculosis infection of host cells in space and time","volume":"43","author":"Bussi","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The Innate Immune Response to Mycobacterium tuberculosis Infection","volume":"39","author":"Stanley","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e230143","DOI":"10.1590\/0074-02760230143","article-title":"Histone deacetylase (HDAC) inhibitors- based drugs are effective to control Mycobacterium tuberculosis infection and promote the sensibility for rifampicin in MDR strain","volume":"118","year":"2023","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4161\/viru.22586","article-title":"The role of dendritic cells in Mycobacterium tuberculosis infection","volume":"3","author":"Mihret","year":"2012","journal-title":"Virulence"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tube.2012.10.008","article-title":"Dendritic cell subsets in mycobacterial infection: Control of bacterial growth and T cell responses","volume":"93","author":"Prendergast","year":"2013","journal-title":"Tuberculosis"},{"key":"ref_15","first-page":"139127","article-title":"The tuberculous granuloma: An unsuccessful host defence mechanism providing a safety shelter for the bacteria?","volume":"2012","author":"Breiman","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.chom.2012.07.009","article-title":"Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages","volume":"12","author":"Yang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jena, P., Mohanty, S., Mohanty, T., Kallert, S., Morgelin, M., Lindstrom, T., Borregaard, N., Stenger, S., Sonawane, A., and Sorensen, O.E. (2012). Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050345"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2017.09.003","article-title":"tuberculosis-Induced Necrosis of Infected Neutrophils Promotes Bacterial Growth Following Phagocytosis by Macrophages","volume":"22","author":"Dallenga","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1189\/jlb.4A0713-363RR","article-title":"NK cells kill mycobacteria directly by releasing perforin and granulysin","volume":"96","author":"Lu","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Larsen, S.E., Williams, B.D., Rais, M., Coler, R.N., and Baldwin, S.L. (2022). It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.840225"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lewinsohn, D.M., and Lewinsohn, D.A. (2022). The Missing Link in Correlates of Protective Tuberculosis Immunity: Recognizing the Infected Cell. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.869057"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","article-title":"CD8 T cells and Mycobacterium tuberculosis infection","volume":"37","author":"Lin","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4049\/jimmunol.1800840","article-title":"HBHA-Induced Polycytotoxic CD4(+) T Lymphocytes Are Associated with the Control of Mycobacterium tuberculosis Infection in Humans","volume":"202","author":"Aerts","year":"2019","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107898","DOI":"10.1016\/j.intimp.2021.107898","article-title":"Multifunctional T cell response in active pulmonary tuberculosis patients","volume":"99","author":"Qin","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis","volume":"178","author":"Maglione","year":"2007","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Augenstreich, J., Arbues, A., Simeone, R., Haanappel, E., Wegener, A., Sayes, F., Le Chevalier, F., Chalut, C., Malaga, W., and Guilhot, C. (2017). ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis. Cell Microbiol., 19.","DOI":"10.1111\/cmi.12726"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature12566","article-title":"The ubiquitin ligase parkin mediates resistance to intracellular pathogens","volume":"501","author":"Manzanillo","year":"2013","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cell.2012.06.040","article-title":"tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway","volume":"150","author":"Watson","year":"2012","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000348676","article-title":"Mycobacterium tuberculosis- induced neutrophil extracellular traps activate human macrophages","volume":"5","author":"Braian","year":"2013","journal-title":"J. Innate Immun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Jeong, E.K., Lee, H.J., and Jung, Y.J. (2022). Host-Directed Therapies for Tuberculosis. Pathogens, 11.","DOI":"10.3390\/pathogens11111291"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e141833","DOI":"10.1172\/JCI141833","article-title":"WNT6\/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis","volume":"131","author":"Brandenburg","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wik, J.A., and Skalhegg, B.S. (2022). T Cell Metabolism in Infection. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.840610"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","article-title":"Tuberculosis: Progress and advances in development of new drugs, treatment regimens, and host-directed therapies","volume":"18","author":"Tiberi","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Huang, X., Lowrie, D.B., Fan, X.Y., and Hu, Z. (2024). Natural products in anti-tuberculosis host-directed therapy. Biomed. Pharmacother., 171.","DOI":"10.1016\/j.biopha.2023.116087"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41577-022-00734-z","article-title":"Host-directed immunotherapy of viral and bacterial infections: Past, present and future","volume":"23","author":"Wallis","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/imr.12255","article-title":"New tricks for old dogs: Countering antibiotic resistance in tuberculosis with host-directed therapeutics","volume":"264","author":"Hawn","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.1917","article-title":"Host-directed drug therapy for tuberculosis","volume":"11","author":"Guler","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cubillos-Angulo, J.M., Nogueira, B.M.F., Arriaga, M.B., Barreto-Duarte, B., Araujo-Pereira, M., Fernandes, C.D., Vinhaes, C.L., Villalva-Serra, K., Nunes, V.M., and Miguez-Pinto, J.P. (2022). Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs. Front. Med., 9.","DOI":"10.3389\/fmed.2022.970408"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mily, A., Rekha, R.S., Kamal, S.M., Arifuzzaman, A.S., Rahim, Z., Khan, L., Haq, M.A., Zaman, K., Bergman, P., and Brighenti, S. (2015). Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138340"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Rekha, R.S., Mily, A., Sultana, T., Haq, A., Ahmed, S., Mostafa Kamal, S.M., van Schadewijk, A., Hiemstra, P.S., Gudmundsson, G.H., and Agerberth, B. (2018). Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D(3) as host directed therapy. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3203-9"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/joim.12767","article-title":"Daily adjunctive therapy with vitamin D(3) and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: A randomized controlled trial in Ethiopia","volume":"284","author":"Bekele","year":"2018","journal-title":"J. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"04015","DOI":"10.7189\/jogh.12.04015","article-title":"Effects of Vitamin D supplementation on resolution of fever and cough in children with pulmonary tuberculosis: A randomized double-blind controlled trial in Indonesia","volume":"12","author":"Tamara","year":"2022","journal-title":"J. Glob. Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood-2019-130275","article-title":"IMPACT-TB*: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. *Imatinib Mesylate per Oral As a Clinical Therapeutic for TB","volume":"134","author":"Giver","year":"2019","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cleverley, T.L., Peddineni, S., Guarner, J., Cingolani, F., Garcia, P.K., Koehler, H., Mocarski, E.S., and Kalman, D. (2023). The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011387"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/0883073811398132","article-title":"The role of aspirin in childhood tuberculous meningitis","volume":"26","author":"Schoeman","year":"2011","journal-title":"J. Child. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1186\/s13063-022-06772-1","article-title":"Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): Study protocol for a phase III randomized controlled trial","volume":"23","author":"Maitre","year":"2022","journal-title":"Trials"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13063-024-08133-6","article-title":"Comparative evaluation of intensified short course regimen and standard regimen for adults TB meningitis: A protocol for an open label, multi-center, parallel arms, randomized controlled superiority trial (INSHORT trial)","volume":"25","author":"Inbaraj","year":"2024","journal-title":"Trials"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e33478","DOI":"10.7554\/eLife.33478","article-title":"A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults","volume":"7","author":"Mai","year":"2018","journal-title":"eLife"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4103\/0028-3886.246278","article-title":"Does adjunctive corticosteroid and aspirin therapy improve the outcome of tuberculous meningitis?","volume":"66","author":"Misra","year":"2018","journal-title":"Neurol. India"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13063-023-07448-0","article-title":"SMA-TB: Study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen","volume":"24","author":"Arias","year":"2023","journal-title":"Trials"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMoa2216218","article-title":"Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults","volume":"389","author":"Donovan","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/IDR.S443897","article-title":"Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication","volume":"17","author":"Fu","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1038\/s41467-021-27029-6","article-title":"A Phase I\/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients","volume":"12","author":"Jenum","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e141895","DOI":"10.1172\/JCI141895","article-title":"Doxycycline host-directed therapy in human pulmonary tuberculosis","volume":"131","author":"Miow","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mi, J., Wu, X., and Liang, J. (2024). The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1380848"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Safe, I.P., Amaral, E.P., Araujo-Pereira, M., Lacerda, M.V.G., Printes, V.S., Souza, A.B., Beraldi-Magalhaes, F., Monteiro, W.M., Sampaio, V.S., and Barreto-Duarte, B. (2020). Adjunct N-Acetylcysteine Treatment in Hospitalized Patients with HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.602589"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"EVIDoa2300332","DOI":"10.1056\/EVIDoa2300332","article-title":"Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis","volume":"3","author":"Wallis","year":"2024","journal-title":"NEJM Evid."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(23)00067-1","article-title":"Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: A phase 2b, randomised, open-label, multicentre trial","volume":"23","author":"Cross","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41577-018-0094-3","article-title":"Statins: A viable candidate for host-directed therapy against infectious diseases","volume":"19","author":"Parihar","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/ciab964","article-title":"Randomized Trial of Metformin with Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults with Pulmonary Tuberculosis","volume":"75","author":"Padmapriydarsini","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"102523","DOI":"10.1016\/j.tube.2024.102523","article-title":"Effect of Metformin on systemic chemokine responses during anti-tuberculosis chemotherapy","volume":"148","author":"Padmapriyadarsini","year":"2024","journal-title":"Tuberculosis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.12688\/wellcomeopenres.19455.1","article-title":"Metformin as adjunctive therapy in combination with multidrug treatment for multibacillary leprosy: A protocol for a randomized double-blind, controlled Phase 2 trial in Indonesia (MetLep Trial)","volume":"8","author":"Krismawati","year":"2023","journal-title":"Wellcome Open Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: A prospective, open-label, phase 2, randomised controlled trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Likoti, M., Sebe, M., Edward, V.A., Rassool, M., Ahmed, K., and Fielding, K. (2022). Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0252097"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4049\/jimmunol.1502407","article-title":"Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette-Guerin in Glucocorticoid-Treated Human Macrophages","volume":"197","author":"Steiger","year":"2016","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Adikesavalu, H., Gopalaswamy, R., Kumar, A., Ranganathan, U.D., and Shanmugam, S. (2021). Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium tuberculosis Infection. Medicina, 57.","DOI":"10.3390\/medicina57060522"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Oh, J.E., and Lee, H.K. (2014). Pattern recognition receptors and autophagy. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00300"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"24932","DOI":"10.18632\/oncotarget.15326","article-title":"The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lee, H.J., Kang, S.J., Woo, Y., Hahn, T.W., Ko, H.J., and Jung, Y.J. (2020). TLR7 Stimulation with Imiquimod Induces Selective Autophagy and Controls Mycobacterium tuberculosis Growth in Mouse Macrophages. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01684"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.molimm.2020.08.007","article-title":"Vitamin D\u2014A host directed autophagy mediated therapy for tuberculosis","volume":"127","author":"Periyasamy","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mily, A., Rekha, R.S., Kamal, S.M., Akhtar, E., Sarker, P., Rahim, Z., Gudmundsson, G.H., Agerberth, B., and Raqib, R. (2013). Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: A dose finding study for treatment of tuberculosis. BMC Pulm. Med., 13.","DOI":"10.1186\/1471-2466-13-23"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1080\/15548627.2015.1075110","article-title":"Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages","volume":"11","author":"Rekha","year":"2015","journal-title":"Autophagy"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/infdis\/jiab100","article-title":"Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity","volume":"224","author":"Ahmed","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.chom.2012.03.008","article-title":"Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action","volume":"11","author":"Kim","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1038\/s41467-023-43937-1","article-title":"Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide","volume":"14","author":"Krug","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15252\/emmm.201404137","article-title":"Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion","volume":"7","author":"Schiebler","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Lim, Y.J., Choi, J.A., Choi, H.H., Cho, S.N., Kim, H.J., Jo, E.K., Park, J.K., and Song, C.H. (2011). Endoplasmic reticulum stress pathway-mediated apoptosis in macrophages contributes to the survival of Mycobacterium tuberculosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028531"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Xu, P., Tang, J., and He, Z.G. (2022). Induction of Endoplasmic Reticulum Stress by CdhM Mediates Apoptosis of Macrophage During Mycobacterium tuberculosis Infection. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.877265"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.179.10.6910","article-title":"CCAAT\/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein","volume":"179","author":"Pennini","year":"2007","journal-title":"J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Gupta, P.K., Chakraborty, P., Kumar, S., Singh, P.K., Rajan, M.G., Sainis, K.B., and Kulkarni, S. (2016). G1-4A, a Polysaccharide from Tinospora cordifolia Inhibits the Survival of Mycobacterium tuberculosis by Modulating Host Immune Responses in TLR4 Dependent Manner. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154725"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Alonzi, T., Aiello, A., Sali, M., Delogu, G., Villella, V.R., Raia, V., Nicastri, E., Piacentini, M., and Goletti, D. (2024). Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases. Biomed. Pharmacother., 178.","DOI":"10.1016\/j.biopha.2024.117153"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Boland, R., Heemskerk, M.T., Forn-Cuni, G., Korbee, C.J., Walburg, K.V., Esselink, J.J., Carvalho Dos Santos, C., de Waal, A.M., van der Hoeven, D.C.M., and van der Sar, E. (2023). Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis. mBio, 14.","DOI":"10.1128\/mbio.03024-22"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jiz064","article-title":"Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects","volume":"220","author":"Lachmandas","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/s41467-020-19095-z","article-title":"Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits","volume":"11","author":"Bohme","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Safe, I.P., Lacerda, M.V.G., Printes, V.S., Praia Marins, A.F., Rebelo Rabelo, A.L., Costa, A.A., Tavares, M.A., Jesus, J.S., Souza, A.B., and Beraldi-Magalhaes, F. (2020). Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study). PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0235381"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Raien, A., Davis, S., Zhang, M., Zitser, D., Lin, M., Pitcher, G., Bhalodia, K., Subbian, S., and Venketaraman, V. (2023). Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection. Cells, 12.","DOI":"10.3390\/cells12222653"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"de Almeida, P.E., Pereira de Sousa, N.M., Rampinelli, P.G., Silva, R.V.S., Correa, J.R., and D\u2019Avila, H. (2023). Lipid droplets as multifunctional organelles related to the mechanism of evasion during mycobacterial infection. Front. Cell Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1102643"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874467209666160112123603","article-title":"Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense","volume":"10","author":"Gabor","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.23.0190","article-title":"Atorvastatin improves sputum conversion and chest X-ray severity score","volume":"27","author":"Adewole","year":"2023","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1002\/mco2.353","article-title":"Mycobacterium tuberculosis: Pathogenesis and therapeutic targets","volume":"4","author":"Yang","year":"2023","journal-title":"MedComm"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Babunovic, G.H., DeJesus, M.A., Bosch, B., Chase, M.R., Barbier, T., Dickey, A.K., Bryson, B.D., Rock, J.M., and Fortune, S.M. (2022). CRISPR Interference Reveals That All-Trans-Retinoic Acid Promotes Macrophage Control of Mycobacterium tuberculosis by Limiting Bacterial Access to Cholesterol and Propionyl Coenzyme A. mBio, 13.","DOI":"10.1128\/mbio.03683-21"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Stan, D., Enciu, A.M., Mateescu, A.L., Ion, A.C., Brezeanu, A.C., Stan, D., and Tanase, C. (2021). Natural Compounds with Antimicrobial and Antiviral Effect and Nanocarriers Used for Their Transportation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.723233"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13237-022-00405-3","article-title":"Plant-derived natural products for drug discovery: Current approaches and prospects","volume":"65","author":"Nasim","year":"2022","journal-title":"Nucleus"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phymed.2009.10.019","article-title":"Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen","volume":"17","author":"Agarwal","year":"2010","journal-title":"Phytomedicine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijmyco.2016.06.012","article-title":"Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy","volume":"5","author":"Butov","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/ijpvm.ijpvm_81_22","article-title":"The Effectiveness of Silymarin in the Prevention of Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized Controlled Clinical Trial","volume":"14","author":"Talebi","year":"2023","journal-title":"Int. J. Prev. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Luangchosiri, C., Thakkinstian, A., Chitphuk, S., Stitchantrakul, W., Petraksa, S., and Sobhonslidsuk, A. (2015). A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complement. Altern. Med., 15.","DOI":"10.1186\/s12906-015-0861-7"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Lara-Espinosa, J.V., Arce-Aceves, M.F., Lopez-Torres, M.O., Lozano-Ordaz, V., Mata-Espinosa, D., Barrios-Payan, J., Silva-Islas, C.A., Maldonado, P.D., Marquina-Castillo, B., and Hernandez-Pando, R. (2022). Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23041964"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Gupta, P.K., Jahagirdar, P., Tripathi, D., Devarajan, P.V., and Kulkarni, S. (2023). Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of Mycobacterium tuberculosis through induction of autophagy and augment anti-TB activity of isoniazid in RAW 264.7 macrophages. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1233630"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Tousif, S., Singh, D.K., Mukherjee, S., Ahmad, S., Arya, R., Nanda, R., Ranganathan, A., Bhattacharyya, M., Van Kaer, L., and Kar, S.K. (2017). Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00739"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jat.4288","article-title":"Curcumin attenuates isoniazid-induced hepatotoxicity by upregulating the SIRT1\/PGC-1alpha\/NRF1 pathway","volume":"42","author":"Li","year":"2022","journal-title":"J. Appl. Toxicol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.abb.2019.04.006","article-title":"Role of Sirt1 in innate immune mechanisms against Mycobacterium tuberculosis via the inhibition of TAK1 activation","volume":"667","author":"Yang","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Singh, D.K., Tousif, S., Bhaskar, A., Devi, A., Negi, K., Moitra, B., Ranganathan, A., Dwivedi, V.P., and Das, G. (2021). Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009805"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Dwivedi, V.P., Bhattacharya, D., Yadav, V., Singh, D.K., Kumar, S., Singh, M., Ojha, D., Ranganathan, A., Van Kaer, L., and Chattopadhyay, D. (2017). The Phytochemical Bergenin Enhances T Helper 1 Responses and Anti-Mycobacterial Immunity by Activating the MAP Kinase Pathway in Macrophages. Front. Cell Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00149"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1074\/jbc.RA119.008005","article-title":"The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice","volume":"294","author":"Kumar","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"106809","DOI":"10.1016\/j.intimp.2020.106809","article-title":"[6]-Gingerol exhibits potent anti-mycobacterial and immunomodulatory activity against tuberculosis","volume":"87","author":"Bhaskar","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_109","first-page":"48","article-title":"A Randomized, Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Tolerability of Risorine with Conventional Rifampicin in the Treatment of Newly Diagnosed Pulmonary Tuberculosis Patients","volume":"65","author":"Patel","year":"2017","journal-title":"J. Assoc. Physicians India"},{"key":"ref_110","first-page":"10","article-title":"Berberine Attenuates Isoniazid-lnduced Hepatotoxicity by Modulating Peroxisome Proliferator-Activated Receptor y, Oxidative Stress and Inflammation","volume":"10","author":"Ayman","year":"2014","journal-title":"Int. J. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Pahuja, I., Negi, K., Kumari, A., Agarwal, M., Mukhopadhyay, S., Mathew, B., Chaturvedi, S., Maras, J.S., Bhaskar, A., and Dwivedi, V.P. (2023). Berberine governs NOTCH3\/AKT signaling to enrich lung-resident memory T cells during tuberculosis. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011165"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Ozturk, M., Chia, J.E., Hazra, R., Saqib, M., Maine, R.A., Guler, R., Suzuki, H., Mishra, B.B., Brombacher, F., and Parihar, S.P. (2021). Evaluation of Berberine as an Adjunct to TB Treatment. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.656419"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"111634","DOI":"10.1016\/j.jep.2018.12.008","article-title":"Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection","volume":"243","author":"Dwivedi","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.biocel.2005.10.021","article-title":"Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages","volume":"38","author":"Anand","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1021\/acsbiomaterials.0c00823","article-title":"Targeted Pulmonary Delivery of the Green Tea Polyphenol Epigallocatechin Gallate Controls the Growth of Mycobacterium tuberculosis by Enhancing the Autophagy and Suppressing Bacterial Burden","volume":"6","author":"Sharma","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Chen, M., Deng, J., Li, W., Lin, D., Su, C., Wang, M., Li, X., Abuaku, B.K., Tan, H., and Wen, S.W. (2015). Impact of tea drinking upon tuberculosis: A neglected issue. BMC Public Health, 15.","DOI":"10.1186\/s12889-015-1855-6"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Soh, A.Z., Pan, A., Chee, C.B.E., Wang, Y.T., Yuan, J.M., and Koh, W.P. (2017). Tea Drinking and Its Association with Active Tuberculosis Incidence among Middle-Aged and Elderly Adults: The Singapore Chinese Health Study. Nutrients, 9.","DOI":"10.3390\/nu9060544"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/resp.12762","article-title":"Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection","volume":"21","author":"Bai","year":"2016","journal-title":"Respirology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.xphs.2020.03.018","article-title":"Intramacrophage Delivery of Dual Drug Loaded Nanoparticles for Effective Clearance of Mycobacterium tuberculosis","volume":"109","author":"Jahagirdar","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yang, H., Chen, J., Chen, Y., Jiang, Y., Ge, B., and Hong, L. (2020). Sirtuin inhibits M. tuberculosis -induced apoptosis in macrophage through glycogen synthase kinase-3beta. Arch. Biochem. Biophys., 694.","DOI":"10.1016\/j.abb.2020.108612"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"107283","DOI":"10.1016\/j.intimp.2020.107283","article-title":"Sirt1 activation negatively regulates overt apoptosis in Mtb-infected macrophage through Bax","volume":"91","author":"Yang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.00291-19","article-title":"Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses","volume":"87","author":"Ahmad","year":"2019","journal-title":"Infect. Immun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"102517","DOI":"10.1016\/j.tube.2024.102517","article-title":"Bergenin potentiates BCG efficacy by enriching mycobacteria-specific adaptive memory responses via the Akt-Foxo-Stat4 axis","volume":"147","author":"Mukhopadhyay","year":"2024","journal-title":"Tuberculosis"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tube.2014.04.007","article-title":"Protective efficacy of piperine against Mycobacterium tuberculosis","volume":"94","author":"Sharma","year":"2014","journal-title":"Tuberculosis"},{"key":"ref_125","first-page":"20","article-title":"Role of Risorine in the Treatment of Drug\u2014Susceptible Pulmonary Tuberculosis: A Pilot Study","volume":"64","author":"Vora","year":"2016","journal-title":"J. Assoc. Physicians India"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Rodriguez-Flores, E.M., Mata-Espinosa, D., Barrios-Payan, J., Marquina-Castillo, B., Castanon-Arreola, M., and Hernandez-Pando, R. (2019). A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217457"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.3892\/mmr.2014.2615","article-title":"The protective effect of curcumin against the 19-kDa Mycobacterium tuberculosis protein-induced inflammation and apoptosis in human macrophages","volume":"10","author":"Li","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.febslet.2006.03.071","article-title":"Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF-alpha mRNA expression in human monocytes by allicin","volume":"580","author":"Hasan","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.ijmyco.2016.09.037","article-title":"Morphological changes in experimental tuberculosis resulting from treatment with quercetin and polyvinylpyrrolidone","volume":"5","author":"Butova","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"106634","DOI":"10.1016\/j.intimp.2020.106634","article-title":"Quercetin attenuates NLRP3 inflammasome activation and apoptosis to protect INH-induced liver injury via regulating SIRT1 pathway","volume":"85","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1139\/cjpp-2021-0008","article-title":"Quercetin modulates NRF2 and NF-kappaB\/TLR-4 pathways to protect against isoniazid- and rifampicin-induced hepatotoxicity in vivo","volume":"99","author":"Sanjay","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Lee, Y.Y., and Tee, V. (2023). Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment. Drugs Context, 12, eCollection 2023.","DOI":"10.7573\/dic.2023-2-11"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Chen, Q., Hu, A., Ma, A., Jiang, F., Xiao, Y., Chen, Y., Huang, R., Yang, T., and Zhou, J. (2022). Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.813682"},{"key":"ref_134","first-page":"138","article-title":"Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: A randomized clinical trial","volume":"12","author":"Marjani","year":"2019","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4046\/trd.2017.80.3.265","article-title":"Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity","volume":"80","author":"Heo","year":"2017","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_136","first-page":"247","article-title":"Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial","volume":"15","author":"Marjani","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/jgh.13070","article-title":"Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial","volume":"31","author":"Zhang","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), Younes, M., Aggett, P., Aguilar, F., Crebelli, R., Dusemund, B., Filipi\u010d, M., Frutos, M.J., Galtier, P., and Gott, D. (2018). Scientific opinion on the safety of green tea catechins. EFSA J., 16, e05239.","DOI":"10.2903\/j.efsa.2018.5239"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yrtph.2018.03.019","article-title":"The safety of green tea and green tea extract consumption in adults\u2014Results of a systematic review","volume":"95","author":"Hu","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"9723686","DOI":"10.1155\/2020\/9723686","article-title":"Prooxidant Effects of Epigallocatechin-3-Gallate in Health Benefits and Potential Adverse Effect","volume":"2020","author":"Ouyang","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e981","DOI":"10.1212\/NXI.0000000000000981","article-title":"Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial","volume":"8","author":"Paul","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1535370220962708","article-title":"Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects","volume":"246","author":"Chatree","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1212\/NXI.0000000000000964","article-title":"Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial","volume":"8","author":"Rust","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Yin, X., Zhu, W., Tang, X., Yang, G., Zhao, X., Zhao, K., Jiang, L., Li, X., Zhao, H., and Wang, X. (2024). Phase I\/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12228-3"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1700447","DOI":"10.1002\/mnfr.201700447","article-title":"Safety Aspects of the Use of Quercetin as a Dietary Supplement","volume":"62","author":"Andres","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2147\/IJGM.S318949","article-title":"Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial","volume":"14","author":"Iqtadar","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e000392","DOI":"10.1136\/bmjresp-2018-000392","article-title":"Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease","volume":"7","author":"Han","year":"2020","journal-title":"BMJ Open Respir. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.hjc.2023.08.004","article-title":"Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study","volume":"76","author":"Kozhukhov","year":"2024","journal-title":"Hellenic J. Cardiol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Yang, K., Chen, J., Zhang, T., Yuan, X., Ge, A., Wang, S., Xu, H., Zeng, L., and Ge, J. (2022). Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.949746"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10637-006-9019-2","article-title":"A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients","volume":"25","author":"Flaig","year":"2007","journal-title":"Investig. New Drugs"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/ptr.7537","article-title":"Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial","volume":"36","author":"Aryan","year":"2022","journal-title":"Phytother. Res."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Sharifi-Rad, J., Rayess, Y.E., Rizk, A.A., Sadaka, C., Zgheib, R., Zam, W., Sestito, S., Rapposelli, S., Neffe-Skocinska, K., and Zielinska, D. (2020). Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01021"},{"key":"ref_153","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer. Res."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Doostkam, A., Iravani, K., Malekmakan, L., Gholamabbas, G., Roozbeh, J., and Soltaniesmaeili, A. (2024). The effectiveness of curcumin as a safe agent on hearing threshold improvement in patients with chronic kidney disease: A double-blind, placebo-controlled trial. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-68572-8"},{"key":"ref_155","first-page":"160","article-title":"Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study","volume":"14","author":"Noppakun","year":"2024","journal-title":"Cardiorenal Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s13063-024-08354-9","article-title":"Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: A randomized double-blind clinical trial","volume":"25","author":"Soltani","year":"2024","journal-title":"Trials"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12937-024-01022-3","article-title":"Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: A randomized controlled trial","volume":"23","author":"Yaikwawong","year":"2024","journal-title":"Nutr. J."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Yaikwawong, M., Jansarikit, L., Jirawatnotai, S., and Chuengsamarn, S. (2024). The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial. Nutrients, 16.","DOI":"10.3390\/nu16152441"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Garcia-Martinez, B.I., Ruiz-Ramos, M., Pedraza-Chaverri, J., Santiago-Osorio, E., and Mendoza-Nunez, V.M. (2023). Effect of Resveratrol on Markers of Oxidative Stress and Sirtuin 1 in Elderly Adults with Type 2 Diabetes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087422"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"102819","DOI":"10.1016\/j.ctim.2022.102819","article-title":"Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial","volume":"66","author":"Mahjabeen","year":"2022","journal-title":"Complement. Ther. Med."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Shaito, A., Posadino, A.M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W.M., Eid, A.H., and Nasrallah, G.K. (2020). Potential Adverse Effects of Resveratrol: A Literature Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062084"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Zeng, Y., Pan, Z., Jin, Y., Li, Q., Pang, J., Wang, X., Chen, Y., Yang, Y., and Ling, W. (2023). A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia. Nutrients, 15.","DOI":"10.3390\/nu15030492"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.12154","article-title":"A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma","volume":"160","author":"Popat","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"110821","DOI":"10.1016\/j.exger.2019.110821","article-title":"Higher dose of resveratrol elevated cardiovascular disease risk biomarker levels in overweight older adults\u2014A pilot study","volume":"131","author":"Mankowski","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Li, J., Zhang, C., Xu, Y., and Yang, L. (2024). Efficacy and safety of berberine plus 5-ASA for ulcerative colitis: A systematic review and meta-analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0309144"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13073-021-00942-7","article-title":"Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: A multi-center, double-blind, randomized, parallel-controlled study","volume":"13","author":"Ming","year":"2021","journal-title":"Genome Med."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Panigrahi, A., and Mohanty, S. (2023). Efficacy and safety of HIMABERB(R) Berberine on glycemic control in patients with prediabetes: Double-blind, placebo-controlled, and randomized pilot trial. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-023-01442-y"},{"key":"ref_168","first-page":"6718","article-title":"Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): A randomized double-blind placebo-controlled clinical trial","volume":"27","author":"Rondanelli","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Zhao, J.V., Yeung, W.F., Chan, Y.H., Vackova, D., Leung, J.Y.Y., Ip, D.K.M., Zhao, J., Ho, W.K., Tse, H.F., and Schooling, C.M. (2021). Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial. Nutrients, 13.","DOI":"10.3390\/nu13082550"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Bandala, C., Carro-Rodriguez, J., Cardenas-Rodriguez, N., Pena-Montero, I., Gomez-Lopez, M., Hernandez-Roldan, A.P., Huerta-Cruz, J.C., Munoz-Gonzalez, F., Ignacio-Mejia, I., and Dominguez, B. (2024). Comparative Effects of Gymnema sylvestre and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study. Nutrients, 16.","DOI":"10.3390\/nu16142284"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1007\/s00210-024-03199-0","article-title":"Research progress on pharmacological effects and bioavailability of berberine","volume":"397","author":"Cui","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes","volume":"12","author":"Harrison","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/13880209.2023.2248167","article-title":"Efficacy and safety of berberine for premature ventricular contractions: A meta-analysis and systematic review of randomized controlled trials","volume":"61","author":"Qiao","year":"2023","journal-title":"Pharm. Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2174\/1570159X20666220420113513","article-title":"Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial","volume":"20","author":"Vaira","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Ntalouka, F., and Tsirivakou, A. (2023). Luteolin: A promising natural agent in management of pain in chronic conditions. Front. Pain Res., 4.","DOI":"10.3389\/fpain.2023.1114428"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00273398","article-title":"Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia","volume":"18","author":"Preisler","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Terzo, S., Amato, A., Magan-Fernandez, A., Castellino, G., Calvi, P., Chianetta, R., Giglio, R.V., Patti, A.M., Nikolic, D., and Firenze, A. (2023). A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study. Nutrients, 15.","DOI":"10.3390\/nu15020462"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jand.2023.09.003","article-title":"Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial","volume":"124","author":"Crichton","year":"2024","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.tjnut.2023.09.002","article-title":"Effect of Ginger Root Powder on Gastrointestinal Bacteria Composition, Gastrointestinal Symptoms, Mental Health, Fatigue, and Quality of Life: A Double-Blind Placebo-Controlled Trial","volume":"153","author":"Crichton","year":"2023","journal-title":"J. Nutr."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Ivashkin, V.T., Kudryavtseva, A.V., Krasnov, G.S., Poluektov, Y.M., Morozova, M.A., Shifrin, O.S., Beniashvili, A.G., Mamieva, Z.A., Kovaleva, A.L., and Ulyanin, A.I. (2022). Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0263880"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Dludla, P.V., Cirilli, I., Marcheggiani, F., Silvestri, S., Orlando, P., Muvhulawa, N., Moetlediwa, M.T., Nkambule, B.B., Mazibuko-Mbeje, S.E., and Hlengwa, N. (2023). Bioactive Properties, Bioavailability Profiles, and Clinical Evidence of the Potential Benefits of Black Pepper (Piper nigrum) and Red Pepper (Capsicum annum) against Diverse Metabolic Complications. Molecules, 28.","DOI":"10.3390\/molecules28186569"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Ziegenhagen, R., Heimberg, K., Lampen, A., and Hirsch-Ernst, K.I. (2021). Safety Aspects of the Use of Isolated Piperine Ingested as a Bolus. Foods, 10.","DOI":"10.3390\/foods10092121"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Salimo, Z.M., Yakubu, M.N., da Silva, E.L., de Almeida, A.C.G., Chaves, Y.O., Costa, E.V., da Silva, F.M.A., Tavares, J.F., Monteiro, W.M., and de Melo, G.C. (2023). Chemistry and Pharmacology of Bergenin or Its Derivatives: A Promising Molecule. Biomolecules, 13.","DOI":"10.3390\/biom13030403"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1017\/S0954422410000338","article-title":"Garlic in health and disease","volume":"24","author":"Rana","year":"2011","journal-title":"Nutr. Res. Rev."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"19207","DOI":"10.1021\/acs.jafc.3c05602","article-title":"Bioavailability, Health Benefits, and Delivery Systems of Allicin: A Review","volume":"71","author":"Deng","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Mehmood, S., Maqsood, M., Mahtab, N., Khan, M.I., Sahar, A., Zaib, S., and Gul, S. (2022). Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies. J. Food Biochem., 46.","DOI":"10.1111\/jfbc.14189"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Aghababaei, F., and Hadidi, M. (2023). Recent Advances in Potential Health Benefits of Quercetin. Pharmaceuticals, 16.","DOI":"10.3390\/ph16071020"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Carrillo-Martinez, E.J., Flores-Hernandez, F.Y., Salazar-Montes, A.M., Nario-Chaidez, H.F., and Hernandez-Ortega, L.D. (2024). Quercetin, a Flavonoid with Great Pharmacological Capacity. Molecules, 29.","DOI":"10.20944\/preprints202402.0029.v1"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/1568026621666211015092654","article-title":"Bergenin\u2014A Biologically Active Scaffold: Nanotechnological Perspectives","volume":"22","author":"Madaan","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Shen, L., Liu, C.C., An, C.Y., and Ji, H.F. (2016). How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies. Sci. Rep., 6.","DOI":"10.1038\/srep20872"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Yucel, C., Karatoprak, G.S., Acikara, O.B., Akkol, E.K., Barak, T.H., Sobarzo-Sanchez, E., Aschner, M., and Shirooie, S. (2022). Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.902551"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1039\/D1FO01971F","article-title":"A review on the bioavailability, bio-efficacies and novel delivery systems for piperine","volume":"12","author":"Zhang","year":"2021","journal-title":"Food Funct."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"111314","DOI":"10.1016\/j.foodres.2022.111314","article-title":"A review of nanostructured delivery systems for the encapsulation, protection, and delivery of silymarin: An emerging nutraceutical","volume":"156","author":"Zhang","year":"2022","journal-title":"Food Res. Int."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ejmech.2015.01.020","article-title":"Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis","volume":"92","author":"Baldwin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1002\/ptr.8255","article-title":"Berberine and berberine nanoformulations in cancer therapy: Focusing on lung cancer","volume":"38","author":"Hsu","year":"2024","journal-title":"Phytother. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/2589977515666221101153730","article-title":"Synergistic Effect of Piperine and its Derivatives: A Comprehensive Review","volume":"15","author":"Saini","year":"2023","journal-title":"Curr. Drug Res. Rev."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1497\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:38:27Z","timestamp":1760114307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":196,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["biom14121497"],"URL":"https:\/\/doi.org\/10.3390\/biom14121497","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,24]]}}}